hizentra
csl behring gmbh - human normal immunoglobulin (scig) - immunologiske mangelsyndrom - immune sera og immunglobuliner, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.
gardasil 9
orifarm as - humant papillomavirus, type 6 l1 protein, rekombinant / humant papillomavirus, type 11 l1 protein, rekombinant / humant papillomavirus, type 16 l1 protein, rekombinant / humant papillomavirus, type 18 l1 protein, rekombinant / humant papillomavirus, type 31 l1 protein, rekombinant / humant papillomavirus, type 33 l1 protein, rekombinant / humant papillomavirus, type 45 l1 protein, rekombinant / humant papillomavirus, type 52 l1 protein, rekombinant / humant papillomavirus, type 58 l1 protein, rekombinant - injeksjonsvæske, suspensjon
venticoll 0.5 mg
ge healthcare as - albumin, humant, kolloidale partikler - pulver til inhalasjonsvæske til nebulisator, oppløsning - 0.5 mg
aprokam 50 mg
laboratoires théa s.a.s - cefuroksimnatrium - pulver til injeksjonsvæske, oppløsning - 50 mg
azyter 15 mg/ g
laboratoires théa s.a.s - azitromycindihydrat - Øyedråper, oppløsning - 15 mg/ g
duokopt 20 mg/ ml / 5 mg/ ml
laboratoires théa s.a.s - dorzolamidhydroklorid / timololmaleat - Øyedråper, oppløsning - 20 mg/ ml / 5 mg/ ml
monoprost 50 mikrog/ ml
laboratoires théa s.a.s - latanoprost - Øyedråper, oppløsning - 50 mikrog/ ml
mydane
laboratoires thea s.a.s - tropikamid / fenylefrinhydroklorid / lidokainhydrokloridmonohydrat - injeksjonsvæske, oppløsning - 0.2 mg/ ml / 3.1 mg/ ml / 10 mg/ ml
oculac 50 mg/ ml
laboratoires théa s.a.s - povidon - Øyedråper, oppløsning i endosebeholder - 50 mg/ ml
oculac 50 mg/ ml
laboratoires théa s.a.s - povidon - Øyedråper, oppløsning - 50 mg/ ml